Phenylalaninol derivatives

Details Phenylalaninol derivatives Phenylalaninol derivatives

2000-02-17

2002-07-16

Shah, Mukund J. (Department: 1642)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acids and salts thereof

C562S576000, C564S149000, C564S151000, C564S123000

Reexamination Certificate

active

06420600

ABSTRACT:

BACKGROUND OF THE INVENTION
Vascular cell adhesion molecule-1 (VCAM-1), a member of the immunoglobulin (Ig) supergene family, is expressed on activated, but not resting, endothelium. The integrin VLA-4 (a
4
b
1
), which is expressed on many cell types including circulating lymphocytes, eosinophils, basophils, and monocytes, but not neutrophils, is the principal receptor for VCAM-1. Antibodies to VCAM-1 or VLA-4 can block the adhesion of these mononuclear leukocytes, as well as melanoma cells, to activated endothelium in vitro. Antibodies to either protein have been effective at inhibiting leukocyte infiltration and preventing tissue damage in several animal models of inflammation. Anti-VLA-4 monoclonal antibodies have been shown to block T-cell emigration in adjuvant-induced arthritis, prevent eosinophil accumulation and bronchoconstriction in models of asthma, and reduce paralysis and inhibit monocyte and lymphocyte infiltration in experimental autoimmune encephalitis (EAE). Anti-VCAM-1 monoclonal antibodies have been shown to prolong the survival time of cardiac allografts. Recent studies have demonstrated that anti-VLA-4 mAbs can prevent insulitis and diabetes in non-obese diabetic mice, and significantly attenuate inflammation in the cotton-top tamarin model of colitis.
Thus, compounds which inhibit the interaction between &agr;
4
-containing integrins, such as VLA-4, and VCAM-1 are useful as therapeutic agents for the treatment of inflammation caused by chronic inflammatory diseases such as rheumatoid arthritis (RA), multiple sclerosis (MS), pulmonary inflammation (e.g., asthma), and inflammatory bowel disease (IBD).
These applications disclose the acids and esters corresponding to the alcohol compounds of this invention and the method of preparing these acids and esters. The disclosure of these U.S. patent applications are hereby incorporated by reference.
SUMMARY OF THE INVENTION
It has been discovered that compounds of the formula:
and the pharmaceutically acceptable salts and esters thereof wherein X and Y are as defined below, are more readily absorbed and more bioavailable than the corresponding carboxylic acids from which they are derived, both of which are effective inhibitors of the binding of VCAM-1 to VLA-4 in vivo and are useful in treating inflammation in inflammatory diseases in which such binding acts to bring on the inflammation.


REFERENCES:
patent: 3023235 (1962-02-01), Leonard
patent: 3527793 (1970-09-01), Holdrege
patent: 5463116 (1995-10-01), Sumikawa et al.
patent: 5804595 (1998-09-01), Portoghese et al.
patent: 2004127 (1990-06-01), None
patent: 195 48 709 (1997-07-01), None
patent: 196 54 483 (1998-01-01), None
patent: 0 207 681 (1987-01-01), None
patent: 848000 (1998-06-01), None
patent: WO 95/35296 (1995-12-01), None
patent: WO 96/22966 (1996-08-01), None
patent: WO 97/36859 (1997-10-01), None
patent: 9736859 (1997-10-01), None
patent: WO 97/36862 (1997-10-01), None
patent: 98 53814 (1998-12-01), None
patent: WO 99/10312 (1999-03-01), None
patent: WO 9910312 (1999-03-01), None
patent: WO 99/10313 (1999-03-01), None
patent: WO 99/43642 (1999-09-01), None
patent: WO 99/48879 (1999-09-01), None
patent: WO 99/61465 (1999-12-01), None
Org. Chem.: Morrison & Boyd, pp. 788,838,839, 1998.*
E. Von Arx, et al., J. Chromatography 1976, vol. 120, pp. 224-228.
Patent Abstracts of Japan vol. 013, No. 029 (C-562), Jan. 23, 1989—JP 63233963 A, Showa Denko.
Abstract corresponding to JP63233963.
Patani, et al., Chemical Reviews, vol. 96, pp. 3147-3176 (1996.
Advanced Organic Chemistry, 2ndEdition, McGraw Hill, pp. 246-259 (1977).
Scheibey, S., et al. Bull. Soc. Chim. Belg. 1978, vol. 87, pp. 229-238.
Cava, M.P., et al. Tetrahedron 1985, vol. 41, pp. 5061-5087.
Meyers, A. I., et al. J. Org. Chem. 1978, vol. 43 pp. 1372-1379.
English Abstract for Document B2—DE 196 54 483.
English Abstract for Document B1—DE 195 48 709.

Affiliated with

Also associated with

Rating

Phenylalaninol derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenylalaninol derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylalaninol derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2823182